comparemela.com

Latest Breaking News On - Hoffmann la roche inc - Page 1 : comparemela.com

Alembic Pharmaceuticals gets 5 USFDA product approvals in Q1FY25

Alembic Pharmaceuticals gets 5 USFDA product approvals in Q1FY25
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United-states
Mexico
India
Canada
Biocon
Alembic-pharmaceuticals-limited-on
Us-food-drug-administration
Consumer-health
Actelion-pharmaceuticals-inc
Hoffmann-la-roche-inc
Bausch-health

Kyverna Therapeutics (NASDAQ:KYTX) & C4 Therapeutics (NASDAQ:CCCC) Financial Review

Kyverna Therapeutics (NASDAQ:KYTX) & C4 Therapeutics (NASDAQ:CCCC) Financial Review
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Emeryville
California
United-states
Watertown
Massachusetts
Merck-sharp-dohme
Kyverna-therapeutics-inc
Biogen-ma-inc
Roche-inc
Betta-pharmaceuticals
Calico-life-sciences

Reviewing ZIVO Bioscience (NASDAQ:ZIVO) and C4 Therapeutics (NASDAQ:CCCC)

C4 Therapeutics (NASDAQ:CCCC – Get Free Report) and ZIVO Bioscience (NASDAQ:ZIVO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Risk and Volatility C4 Therapeutics has a […]

Massachusetts
United-states
Watertown
Bloomfield-hills
Michigan
Bioscience-inc
Roche-inc
Calico-life-sciences
Biogen-ma-inc
Health-enhancement-products-inc
Roche-ltd

EYLEA® (Aflibercept) And Soliris® (Eculizumab) IPR Updates - Patent

On December 8, 2023, the PTAB instituted three of Samsung Bioepis's pending IPRs against Alexion's Soliris® (eculizumab), IPR2023-00933, IPR2023-00998, and IPR2023-00999.

United-states
Frankfurt
Brandenburg
Germany
Stites-harbison
Kurnit-klein-selz
Reddy-laboratories-inc
Roche-inc
National-institute-of-standards
Biogen-inc
Goodwin-procter
Genentech-inc

BPCIA Complaint Against Proposed Rituxan® Biosimilar DRL_RI Filed - Patent

On November 17, 2023, Genentech, Inc., Hoffmann-La Roche Inc., and Biogen Inc. ("Plaintiffs") filed a BPCIA complaint ("Complaint") against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories SA ("DRL SA").

United-states
New-jersey
Fresenius-kabi-deutschland-gmb
April-breyer-menon
Sandoz-gmb
Sanofi-aventis-deutschland-gmb
Fresenius-kabi-swissbiosim
Roche-inc
Fresenius-kabi-united-states
Celltrion-healthcare-co-ltd
Reddy-laboratories-inc
Genentech

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.